Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy
Danielle E Anderson,Jin Cui,Qian Ye,Baoying Huang,Ya Tan,Chao Jiang,Wenhong Zu,Jing Gong,Weiqiang Liu,So Young Kim,Biao Guo Yan,Kristmundur Sigmundsson,Xiao Fang Lim,Fei Ye,Peihua Niu,Aaron T Irving,Haoyu Zhang,Yefeng Tang,Xuming Zhou,Yu Wang,Wenjie Tan,Lin-Fa Wang,Xu Tan
DOI: https://doi.org/10.1073/pnas.2104759118
2021-09-28
Abstract:Bats are responsible for the zoonotic transmission of several major viral diseases, including those leading to the 2003 SARS outbreak and likely the ongoing COVID-19 pandemic. While comparative genomics studies have revealed characteristic adaptations of the bat innate immune system, functional genomic studies are urgently needed to provide a foundation for the molecular dissection of the viral tolerance in bats. Here we report the establishment of genome-wide RNA interference (RNAi) and CRISPR libraries for the screening of the model megabat, Pteropus alecto. We used the complementary RNAi and CRISPR libraries to interrogate P. alecto cells for infection with two different viruses: mumps virus and influenza A virus, respectively. Independent screening results converged on the endocytosis pathway and the protein secretory pathway as required for both viral infections. Additionally, we revealed a general dependence of the C1-tetrahydrofolate synthase gene, MTHFD1, for viral replication in bat cells and human cells. The MTHFD1 inhibitor, carolacton, potently blocked replication of several RNA viruses, including SARS-CoV-2. We also discovered that bats have lower expression levels of MTHFD1 than humans. Our studies provide a resource for systematic inquiry into the genetic underpinnings of bat biology and a potential target for developing broad-spectrum antiviral therapy.